共 41 条
[21]
Phase II trial of hypofractionated image-guided intensitymodulated radiotherapy for localized prostate adenocarcinoma
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2007, 69 (04)
:1084-1089
[22]
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2000, 46 (02)
:391-402
[23]
Influence of rectal volume changes during radiotherapy for prostate cancer:: A predictive model for mild-tomoderate late rectal toxicity
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2003, 57 (05)
:1280-1284
[24]
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2006, 64 (04)
:1151-1161
[25]
An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2007, 67 (05)
:1430-1437
[26]
Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 53 (05)
:1097-1105
[27]
*RAD THER ONC GROU, RTOG 0415 PHAS 3 RAN
[28]
Radiation Therapy Oncology Group, RTOG 0126 PHAS 3 RAN
[29]
HYPOFRACTIONATED RADIOTHERAPY FOR FAVORABLE RISK PROSTATE CANCER
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2010, 77 (03)
:805-810
[30]
Interim report of toxicity from 3D conformal radiation therapy (3Dd-CRT) for prostate cancer on 3DOG/RTOg 9406, level III (79.2 Gy)
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 54 (04)
:1036-1046